Background Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease
associated with systemic changes in immune response, which might be associated with …

The COVID-19 pandemic was and still is a global burden with more than 178,000,000 cases
reported so far. Although it mainly affects respiratory organs, COVID-19 has many …

Non-alcoholic fatty liver disease (NAFLD) is identified as a risk factor for developing severe
COVID-19. While NAFLD is associated with chronic low-grade inflammation, mechanisms …

Background The presence of metabolic syndrome (MS) is associated with increased
disease severity in patients with coronavirus disease 2019 (COVID-19). Non-alcoholic fatty …

Background & aims Although metabolic risk factors are associated with more severe COVID-
19, there is little evidence on outcomes in patients with non-alcoholic fatty liver disease …

Aim Coronavirus disease 2019 (COVID-19) is a recently encountered disease that was
declared a pandemic by WHO in 2020. Obesity and other components of the metabolic …

It is important to identify risk factors for poor outcomes of coronavirus disease 2019 (COVID-
19) patients. Currently, the correlation between non-alcoholic fatty liver disease (NAFLD) …

Background & Aims The coronavirus disease 2019 (COVID-19) pandemic has witnessed
more than 4.5 million deaths as of the time of writing. Whether nonalcoholic fatty liver …

Previous studies reported that coronavirus disease 2019 (COVID‐19) was likely to result in
liver injury. However, few studies investigated liver injury in patients with COVID‐19 with …

This study aims to evaluate the effect of non‐alcoholic fatty liver disease (NAFLD) on the
susceptibility and consequences of coronavirus disease 2019 (COVID‐19). We …